The US endoscopy capsules market revenue is projected to grow robustly, with total revenues reaching 455 million USD in 2025 and showing sustained CAGR through 2035. This trajectory reflects increased diagnostic demand, clinical adoption in ambulatory settings, and ongoing product innovation by key market players. The chart underscores a consistent upward momentum, driven by both increased incidence of GI conditions and expanded insurance coverage for non-invasive diagnostics. Gradual entry of new competing technologies and providers is expected to diversify the revenue base further by 2030.

Read More - https://bussinessinsights.com/research-report/us-endoscopy-capsules

In 2025, obscure GI bleeding remains the leading application for endoscopy capsules in the US, owing to the challenges of diagnosing the precise source of bleeding within the small intestine using conventional techniques. Crohn’s disease is the second-largest segment, supported by the increasing prevalence and high diagnostic value of capsule technology in assessing disease extent. Applications such as small intestine tumor detection and inherited polyposis syndromes are witnessing increased adoption due to their minimally invasive nature and comprehensive imaging capabilities. Others, including celiac disease monitoring, add to the expanding versatility of capsule endoscopy technology. This distribution reflects a dynamic shift towards personalized, indication-driven capsule deployments in both hospital and ambulatory care settings.

Request Free Sample- https://bussinessinsights.com/request/medical-devices/us-endoscopy-capsules

Frequently Asked Questions

Who are the key players in US Endoscopy Capsules industry?
The top 5 players in the US Endoscopy Capsules industry are Medtronic, Olympus Corporation, IntroMedic, CapsoVision, and Jinshan Science & Technology. These companies lead the market due to their innovative products, robust research and development, wide distribution networks, and strategic collaborations to expand their endoscopic solutions across the US healthcare system.

What is the US Endoscopy Capsules growth?
The US Endoscopy Capsules market has seen significant growth, driven by rising gastrointestinal disease prevalence and increasing preference for minimally invasive diagnostics. For instance, Medtronic reported notable sales growth in its GI business segment in 2023, underscoring heightened demand and rapid market expansion for capsule endoscopy solutions.

Which segment accounted for the largest US Endoscopy Capsules share?
The largest share in the US Endoscopy Capsules market comes from the gastrointestinal diseases application segment, particularly in diagnosis of small bowel disorders such as Crohn’s disease and obscure gastrointestinal bleeding. This segment leads due to the need for non-invasive, patient-friendly diagnostic tools replacing traditional endoscopy.

Thanks & Regards,
Manisha C
sales@bussinessinsights.com